Patents by Inventor John G Allen

John G Allen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apelin polypeptides
    Patent number: 10941182
    Abstract: The invention provides modified apelin polypeptides having increased stability, circulating half-life, and/or potency relative to the native apelin-13 polypeptide. Compositions comprising the modified apelin polypeptides and methods of using the polypeptides for treating cardiac disorders, such as heart failure, are also disclosed.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: March 9, 2021
    Assignee: Amgen Inc.
    Inventors: Jerry Ryan Holder, Gayathri Swaminath, Michael J. Frohn, Brian Alan Lanman, Anthony B. Reed, Leslie P. Miranda, John G. Allen, Alexander J. Pickrell, Aaron C. Siegmund, Lewis D. Pennington, Bryant Yang
  • APELIN POLYPEPTIDES
    Publication number: 20170107255
    Abstract: The invention provides modified apelin polypeptides having increased stability, circulating half-life, and/or potency relative to the native apelin-13 polypeptide. Compositions comprising the modified apelin polypeptides and methods of using the polypeptides for treating cardiac disorders, such as heart failure, are also disclosed.
    Type: Application
    Filed: June 10, 2015
    Publication date: April 20, 2017
    Applicant: AMGEN INC.
    Inventors: Jerry Ryan HOLDER, Gayathri SWAMINATH, Michael J. FROHN, Brian Alan LANMAN, Anthony B. REED, Leslie P. Miranda, John G. Allen, Alexander J. Pickrell, Aaron C. Siegmund, Lewis D. Pennington, Bryant Yang
  • Thiazole compounds and methods of use
    Patent number: 8084479
    Abstract: The invention relates to methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases mediated by protein kinase B (PKB) such as cancer and other proliferative disorders where the variables have the definitions provided herein.
    Type: Grant
    Filed: February 11, 2009
    Date of Patent: December 27, 2011
    Assignee: Amgen Inc.
    Inventors: Qingping Zeng, John G. Allen, Matthew P. Bourbeau, Celia Dominguez, Christopher H. Fotsch, Nianhe Han, Fang-Tsao Hong, Xin Huang, Matthew R. Lee, Aiwen Li, Qingyian Liu, James T. Rider, Seifu Tadesse, Andrew S. Tasker, Vellarkad N. Viswanadhan, Xianghong Wang, Kurt E. Weiler, George E. Wohlhieter, Guomin Yao, Chester Chenguang Yuan
  • FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE
    Publication number: 20110263647
    Abstract: The invention relates to thiazole compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
    Type: Application
    Filed: January 13, 2010
    Publication date: October 27, 2011
    Applicant: AMGEN INC.
    Inventors: Qingping Zeng, Chester Chenguang Yuan, Guomin Yao, Xianghong Wang, Seifu Tadesse, David J. ST. Jean, JR., Andreas Reichelt, Qingyian Liu, Fang-Tsao Hong, Nianhe Han, Christopher H. Fotsch, Carl D. Davis, Matthew P. Bourbeau, Kate S. Ashton, John G. Allen
  • Thiadiazole modulators of PKB
    Patent number: 7919504
    Abstract: The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
    Type: Grant
    Filed: July 15, 2008
    Date of Patent: April 5, 2011
    Assignee: Amgen Inc.
    Inventors: Qingping Zeng, Chester Chenguang Yuan, Guomin Yao, Xianghong Wang, Seifu Tadesse, Andreas Reichelt, Qingyian Liu, Matthew R. Lee, Xin Huang, Fang-Tsao Hong, Nianhe Han, Christopher H. Fotsch, Celia Dominguez, Matthew P. Bourbeau, John G. Allen
  • Heterocyclic modulators of PKB
    Patent number: 7897619
    Abstract: The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
    Type: Grant
    Filed: July 16, 2008
    Date of Patent: March 1, 2011
    Assignee: Amgen Inc.
    Inventors: Qingping Zeng, Dawei Zhang, Guomin Yao, George E. Wohlhieter, Xianghong Wang, James Rider, Andreas Reichelt, Holger Monenschein, Fang-Tsao Hong, James R. Falsey, Celia Dominguez, Matthew P. Bourbeau, John G. Allen
  • Thiadiazole modulators of PKB
    Publication number: 20090298836
    Abstract: The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
    Type: Application
    Filed: July 15, 2008
    Publication date: December 3, 2009
    Applicant: Amgen Inc.
    Inventors: Qingping Zeng, Chester Chenguang Yuan, Guomin Yao, Xianghong Wang, Seifu Tadesse, Andreas Reichelt, Qingyian Liu, Matthew R. Lee, Xin Huang, Fang-Tsao Hong, Nianhe Han, Christopher H. Fotsch, Celia Dominguez, Matthew P. Bourbeau, John G. Allen
  • Heterocyclic modulators of PKB
    Publication number: 20090275592
    Abstract: The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
    Type: Application
    Filed: July 16, 2008
    Publication date: November 5, 2009
    Applicant: Amgen Inc.
    Inventors: Qingping ZENG, Dawei ZHANG, Guomin YAO, George E. WOHLHIETER, Xianghong WANG, James RIDER, Andreas REICHELT, Holger MONENSCHEIN, Fang-Tsao HONG, James R. FALSEY, Celia DOMINGUEZ, Matthew P. BOURBEAU, John G. ALLEN
  • Thiazole compounds and methods of use
    Publication number: 20090270445
    Abstract: The invention relates to methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases mediated by protein kinase B (PKB) such as cancer and other proliferative disorders where the variables have the definitions provided herein.
    Type: Application
    Filed: February 11, 2009
    Publication date: October 29, 2009
    Applicant: Amgen Inc.
    Inventors: Qingping Zeng, John G. Allen, Matthew P. Bourbeau, Celia Dominguez, Christopher H. Fotsch, Nianhe Han, Fang-Tsao Hong, Xin Huang, Matthew R. Lee, Aiwen Li, Qingyian Liu, James T. Rider, Seifu Tadesse, Andrew S. Tasker, Vellarkad N. Viswanadhan, Xianghong Wang, Kurt E. Weiler, George E. Wohlhieter, Guomin Yao, Chester Chenguang Yuan
  • Thiazole compounds and methods of use
    Patent number: 7514566
    Abstract: The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
    Type: Grant
    Filed: January 11, 2007
    Date of Patent: April 7, 2009
    Assignee: Amgen, Inc.
    Inventors: Qingping Zeng, John G. Allen, Matthew P. Bourbeau, Celia Dominguez, Christopher H. Fotsch, Nianhe Han, Fang-Tsao Hong, Xin Huang, Matthew R. Lee, Aiwen Li, Qingyian Liu, James T. Rider, Seifu Tadesse, Andrew S. Tasker, Vellarkad N. Viswanadhan, Xianghong Wang, Kurt E. Weiler, George E. Wohlhieter, Guomin Yao, Chester Chenguang Yuan
  • Afterburner igniter
    Patent number: 7334389
    Abstract: A gas turbine engine afterburner igniter is provided with primary fuel duct means for injecting a jet of fuel into a gas stream directed into a combustion chamber. A spring is positioned within the bore of said fuel duct. The spring being moveable relative to said duct such that during operation said spring moves downstream though the bore due to the passage of fuel therein and returns to it's original position thereafter. During operation the spring abrades the internal surface of the bore thus removing carbon deposits.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: February 26, 2008
    Assignee: Rolls-Royce plc
    Inventor: John G Allen
  • Heat shielding for a turbine combustor
    Patent number: 5974805
    Abstract: A combustor for a gas turbine engine has a fuel nozzle located in the upstream end thereof and is positioned within a cylinder coaxial with said nozzle. The cylinder comprises at its downstream end an annular flange extending from the cylinder in a generally radial direction. The flange has a plurality of cooling air apertures radially extending therethrough so as to direct cooling air along the face of an adjacent heatshield.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: November 2, 1999
    Assignee: Rolls-Royce plc
    Inventor: John G Allen
  • Treatment of dilute acidic solutions
    Patent number: 5443741
    Abstract: A process for the treatment of acidic fluoride-containing solutions to neutralize them and to remove fluoride ion in the form of a readily filterable precipitate which comprises mixing the acidic solution with a suspension of an alkaline earth metal oxide or hydroxide, wherein a flocculating agent is incorporated in the acidic solution before mixing thereof with the alkaline earth metal oxide or hydroxide.
    Type: Grant
    Filed: February 14, 1994
    Date of Patent: August 22, 1995
    Assignee: Imperial Chemical Industries PLC
    Inventors: John A. Stott, John G. Allen